What We Know About Immunotherapy Treatments for Lung Cancer
Immunotherapy Forum Video #23: Dr. Jared Weiss highlights what doctors know about immunotherapy treatments for lung cancer.
Immunotherapy Forum Video #23: Dr. Jared Weiss highlights what doctors know about immunotherapy treatments for lung cancer.
In Part 2 of 2 videos about squamous lung cancer, Dr.
In Part 1 of 2 videos about squamous lung cancer, Dr. Chad Pecot explains what doctors look for and ask about when diagnosing lung cancer, and how you can be sure you received the correct diagnosis.
[powerpress]
Dr. Thomas John of the Olivia Newton-John Cancer Center in Melbourne, Australia presents his favorite breakthroughs in lung cancer from 2014.
For those who wish to access the PDF, it's here: Thomas John, MD Top Four Lung Cancer Highlights 2014
Agree? Disagree? What are you looking forward to in 2015?
There were many advances in lung cancer targeted treatments in 2014. The one that most excites Dr. Geoffrey Oxnard from Dana-Farber Cancer Institute is the use of liquid biopsies.
[powerpress]
I have lived with lung cancer since 2005. On this "Giving Tuesday," I ask that you join me in making an end-of-year donation to an organization that truly deserves it, the Global Resource for Advancing Cancer Education (GRACE).
Dr. Jack West, Dr. Julie Brahmer, and Dr. Ben Creelan discuss the excitement the medical community is feeling about immunotherapy for the treatment of lung cancer. February 2014
[powerpress]
Dr. Robert Doebele explains why he feels that repeat biopsies help researchers better understand why ALK+ lung cancer patients become resistant to current treatments - and why some do better than expected. February 2014
[powerpress]
For ALK+ lung cancer patients, brain metastases are a common concern. Dr. Robert Doebele discusses the options available to treat brain mets as well as drugs that may break through the blood/brain barrier.
Will the success seen for stage IV patients receiving targeted therapies translate into cure for stage III patients? Dr. Daniel Morgensztern of the Washington University School of Medicine talks about what research is ongoing to answer that question.
[powerpress]
Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock